Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,891
Closed -$15K 3161
2025
Q3
$15K Sell
14,891
-15,012
-50% -$17.5K ﹤0.01% 2727
2025
Q2
$49K Sell
29,903
-26,034
-47% -$44.3K ﹤0.01% 2307
2025
Q1
$117K Buy
+55,937
New +$125K ﹤0.01% 2126
2023
Q3
Sell
-4,534
Closed -$25K 2379
2023
Q2
$25K Buy
+4,534
New +$35.3K ﹤0.01% 2076
2022
Q2
Sell
-1,757
Closed -$51K 2907
2022
Q1
$51K Buy
+1,757
New +$64.3K ﹤0.01% 2743
2021
Q4
Sell
-4,243
Closed -$314K 3157
2021
Q3
$551K Buy
+4,243
New +$471K ﹤0.01% 1889
2021
Q2
Sell
-2,385
Closed -$844K 2823
2021
Q1
$844K Buy
2,385
+1,280
+116% +$493K 0.01% 1306
2020
Q4
$228K Buy
+1,105
New +$127K ﹤0.01% 1442

Other funds holding ATER

HRT Financial's ATER Position: Q4 2025 in Review

HRT Financial sold out of Aterian (ATER) in Q4 2025, closing a stake of 14,891 shares — an estimated $15K sold.

HRT Financial first reported a position in ATER in Q4 2020 and held it in 8 quarters. The position peaked at $844K in Q1 2021. 29 funds tracked by Wall St. Rank hold ATER as of Q4 2025.

  • HRT Financial reported no remaining Aterian position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 14,891 Aterian shares in Q4 2025, an estimated $15K.
  • HRT Financial first reported a position in Aterian in Q4 2020 and held it in 8 quarters.
  • HRT Financial's Aterian position peaked at $844K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Aterian as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.